Skip to main content
. 2010 Dec 30;5(12):e15852. doi: 10.1371/journal.pone.0015852

Figure 6. hMena overexpression adds prognostic information in HER2 overexpressing tumors.

Figure 6

Kaplan-Meier estimates of disease-free survival (DFS) for hMena and HER2 status show that hMena/HER2 covariates have a different effect on DFS in relationship to the different phenotype combinations. In particular, the lower percentage of disease free patients at 6 year follow up was found in the group of HER2+/hMena+ tumors (p<0.0001).